The Pulmonary Vasculitides - 05/08/11
Doi : 10.1016/j.ccm.2010.04.005
Stephen K. Frankel, MD a, b, ⁎ 
, David Jayne, MBBchir, MD c
, David Jayne, MBBchir, MD c a Interstitial Lung Disease Program, Critical Care & Hospital Medicine, National Jewish Health, 1400 Jackson Street, G-012, Denver, CO 80206, USA
b Division of Pulmonary Sciences & Critical Care Medicine, Anschutz Medical Campus, University of Colorado School of Medicine, 1645 Ursula Street, Aurora, CO 80045, USA
c Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK
Corresponding author. Interstitial Lung Disease Program, Critical Care & Hospital Medicine, National Jewish Health, 1400 Jackson Street, G-012, Denver, CO 80206.Résumé |
The vasculitides represent a spectrum of disorders characterized by inflammation and destruction of the blood vessel wall, and these entities commonly affect the respiratory system. Although challenging to diagnose and manage, recent advances in the treatment of these disorders has greatly improved the prognosis for patients with vasculitis, and with the advent of increasingly less toxic therapies, the future for these patients is brighter still.
Le texte complet de cet article est disponible en PDF.Keywords : Pulmonary vasculitides, Wegener granulomatosis, Microscopic polyangitiis, Churg-Strauss vasculitis
Plan
© 2010
Elsevier Inc. Tous droits réservés.
Vol 31 - N° 3
P. 519-536 - septembre 2010 Retour au numéro
Article précédent
- Pulmonary Manifestations of Relapsing Polychondritis
- Samaan Rafeq, David Trentham, Armin Ernst
- Pulmonary Manifestations of the Antiphospholipid Antibody Syndrome
- H. James Ford, Robert A.S. Roubey
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?